12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

PAS-GR regulatory update

EMA's CHMP issued a positive opinion recommending approval of Lucane's Para-aminosalicylic acid Lucane to treat multidrug-resistant tuberculosis (MDR-TB)...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >